Head-to-Head

Apnimed, Inc. Common Stock vs. Eli Lilly & Co.

APMD

Apnimed, Inc. Common Stock

$26.22 -9.59%

VS LLY

Eli Lilly & Co.

$1164.89 +1.04%

Apnimed, Inc. Common Stock and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

APMDLLY
Market Cap $1.09 billion $1.03 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) — $26.71 billion

LLY leads on 1 of 1 size & scale factors.

Valuation

APMDLLY
P/E Ratio — 39.10
Price / Book — 30.33
Price / Sales — 12.90

APMD and LLY split the valuation factors evenly.

Profitability

APMDLLY
Net Margin — 33.53%
Return on Equity — 78.84%

APMD and LLY split the profitability factors evenly.

Dividend

APMDLLY
Dividend Yield — 0.59%
Payout Ratio — 23.23

APMD and LLY split the dividend factors evenly.

Risk & Sentiment

APMDLLY
Short Interest 0.98% 1.29%

APMD leads on 1 of 1 risk & sentiment factors.

Dig deeper: APMD overview, APMD financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.